- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 88,860 | 28.05.24 15:35:47 | -0,900 | -1,00% | 0,000 | 0,000 | 89,720 | 89,760 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 901,200 | 28.05.24 08:16:26 | -3,400 | -0,38% | 0,000 | 0,000 | 901,200 | 904,600 |
